印度胰岛素帮浦市场评估：依类型、依产品、依配件、依适应症、依年龄层、依最终用户、依分销管道、依地区、机会、预测（2017 财年-2031 财年）

2023 财年，印度胰岛素帮浦市场规模为 3,180 万美元，预计到 2031 财年将达到 6,063 万美元，2024 财年至 2031 财年预测期间复合年增长率为 8.4%。该市场受到糖尿病患病率上升、对优先考虑便利性和易用性的胰岛素输送设备的需求增加、技术进步、政府举措、老年人口增长以及医疗费用上涨等因素的推动。

印度胰岛素帮浦市场在医疗领域占据中心地位，预计将大幅扩张和发展。随着糖尿病盛行率持续上升，对先进糖尿病管理解决方案的需求变得更加迫切。在此背景下，印度胰岛素帮浦市场已成为技术创新的先驱，为那些寻求更好的血糖调节方法和管理糖尿病管理复杂性的人们带来了希望。这些设备具有以最少的努力提供准确的胰岛素剂量的独特优势，使其成为糖尿病管理的宝贵资产。

政府减轻糖尿病负担和降低医疗费用的努力正在推动印度胰岛素帮浦市场的扩张。提倡采用先进糖尿病管理技术的公共卫生举措和政策改善了胰岛素帮浦的取得和可用性，使广大印度人口受益。此外，印度人口老化也是推动胰岛素帮浦市场扩张的主要因素。容易患糖尿病的老年人需要有效的胰岛素管理解决方案。在此背景下，印度胰岛素帮浦市场成为乐观的源泉，为希望改善糖尿病控制从而提高生活品质的人们提供了一种创新且易于使用的选择。

认知度的提高推动市场成长

印度胰岛素帮浦意识的迅速提高正在对市场产生积极影响。糖尿病患者越来越认识到胰岛素帮浦的好处，包括增强血糖控制和降低低血糖风险。这种日益增长的意识正在推动对胰岛素帮浦的需求并推动市场扩张。此外，印度糖尿病协会等组织在提高人们对胰岛素帮浦的认识、消除相关误解以及努力提高糖尿病患者的可用性和可及性方面发挥着重要作用。随着人们对胰岛素帮浦的认识不断提高，这些设备的印度市场预计将扩大，为胰岛素帮浦开发商和製造商创造机会。

印度老年人口成长

由于人口老化，印度的胰岛素帮浦市场正在经历重大转型。在老年人口迅速膨胀的印度，该年龄层糖尿病尤其是第2型糖尿病的盛行率显着上升。因此，作为有效糖尿病管理的重要工具，对胰岛素帮浦的需求显着增加。老龄化人口对糖尿病的脆弱性强调了精确控制胰岛素的必要性。这些人口变化正在显着改变医疗保健格局，尤其是印度的糖尿病照护。人口老化是罹患糖尿病的高风险。这是由于体力活动减少和肥胖增加等因素所造成的。糖尿病盛行率的增加促使对胰岛素帮浦的需求增加。

政府措施

政府措施在塑造印度胰岛素帮浦市场方面发挥关键作用。印度政府推出了各种政策、计划和补贴，以改善胰岛素帮浦和糖尿病管理技术的可近性，特别是针对经济弱势群体。

例如，2023 年 5 月，州政府宣布打算向第 1 型糖尿病患者提供免费胰岛素帮浦。胰岛素帮浦价格昂贵，对于经济困难的患者来说难以负担。因此，如果没有泵，这些患者就会依赖每天注射胰岛素，并且更容易受到影响肾臟等重要器官的严重感染。

本报告研究和分析了印度胰岛素帮浦市场，提供市场规模和预测、市场动态、主要参与者的现状和前景等。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章 COVID-19 对印度胰岛素帮浦市场的影响

第 4 章执行摘要

第五章印度胰岛素帮浦市场展望（2017财政年度-2031财政年度）

• 市场规模与预测
  • 金额
  • 数量
• 依类型
  • 独立胰岛素帮浦
  • 内建感测器的胰岛素泵
• 依产品
  • 泵
  • 消耗品
• 依配件
  • 胰岛素储液器、药筒
  • 胰岛素套件插入装置
  • 电池
• 依指示
  • 1 型糖尿病
  • 2 型糖尿病
• 依年龄
  • 成人
  • 儿童
  • 双重用途
• 依最终用户
  • 医院
  • 诊所
  • 首页
  • 实验室
• 依分销管道
  • 零售店
  • 医院药房
  • 电子商务
• 依地区
  • 北
  • 南部
  • 东方
  • 西部和中部地区
• 市占率：依公司划分（2023 财年）

第 6 章市场地图（2023 财年）

• 依类型
• 依产品
• 依配件
• 依指示
• 依年龄
• 依最终用户
• 依分销管道
• 依地区

第七章宏观环境与产业结构

• 需求与供给分析
• 进出口分析
• 价值链分析
• PESTEL 分析
• 波特五力分析

第 8 章市场动态

• 生长促进因素
• 抑製成长的因素（问题、限制因素）

第 9 章监理架构与创新

• 临床试验
• 专利情况
• 监理机关的核准
• 创新/新技术

第十章主要公司状况

• 前 5 名市场领导者的竞争矩阵
• 前 5 位市场领导者的市场收入分析（2023 财年）
• 併购/合资企业（如果适用）
• SWOT 分析（5 家市场公司）
• 专利分析（如果适用）

第11章价格分析

第 12 章案例研究

第十三章主要公司展望

• India Medtronic Pvt. Ltd.
• Agva Healthcare Pvt. Ltd.
• Ypsomed India Pvt. Ltd.
• Tandem Diabetes Care, Inc.

第14章战略建议

第十五章关于我们公司，免责声明

India insulin pumps market size was valued at USD 31.8 million in FY2023, which is expected to reach USD 60.63 million in FY2031, with a CAGR of 8.4% for the forecast period between FY2024 and FY2031. India insulin pumps market is being driven by factors including the rising prevalence of diabetes, increasing demand for insulin delivery devices that prioritize convenience and user-friendliness, technological advancements, government initiatives, growing elderly population, and increasing healthcare expenditure.

India insulin pumps market holds a central position in the healthcare arena and is poised for significant expansion and evolution. As prevalence of diabetes continue to rise, the need for advanced diabetes management solutions becomes more serious. In this context, the insulin pumps market in India stands as a pioneer of innovation, providing hope for individuals navigating the complexities of diabetes management for seeking enhanced methods of blood glucose regulation. These devices offer the distinct advantage of delivering precise insulin doses with minimal effort, rendering them invaluable assets in the realm of diabetes management.

Government efforts to alleviate the diabetes burden and reduce healthcare expenses are driving the expansion of India insulin pumps market. Public health initiatives and policies advocating the adoption of advanced diabetes management technologies have improved insulin pump accessibility and affordability, benefiting a wider cross-section of the Indian populace. Moreover, India's aging demographics is a key factor in the growing insulin pumps market. The elderly population, prone to diabetes, requires efficient insulin management solutions. In this context, the India insulin pumps market emerges as a source of optimism, presenting innovative and accessible choices for individuals striving to achieve improved diabetes control and ultimately enhancing their quality of life.

Heightened Awareness is Propelling Market Growth

The surging awareness of insulin pumps in India is exerting a favourable influence on the India insulin pumps market. Individuals with diabetes increasingly recognize the advantages of insulin pumps, including enhanced blood sugar management and reduced hypoglycaemia risk. This heightened awareness is driving the demand for insulin pumps, fostering market expansion. Additionally, organizations such as the Indian Diabetes Association are playing a crucial role in rising awareness about insulin pumps, dispelling associated misconceptions, and striving to enhance affordability and accessibility for individuals with diabetes. As awareness of insulin pumps continues to rise, the Indian market for these devices is anticipated to expand, creating opportunities for insulin pump developers and manufacturers.

Increasing India's Ageing Population

India insulin pumps market is experiencing a notable transformation driven by the country's aging demographics. With a swiftly expanding elderly population, India is encountering a remarkable increase in the incidence of diabetes, notably Type 2 diabetes, within this age cohort. Consequently, there has been a substantial rise in the demand for insulin pumps as a pivotal instrument for effective diabetes management. The elderly demographic's inherent vulnerability to diabetes underscores the vital necessity for precise insulin control. This demographic shift is reshaping the healthcare landscape, particularly in the context of diabetes care in India. The ageing population is at a higher risk of developing diabetes. It is due to several factors, including the decline in physical activity and the increase in obesity. The increasing prevalence of diabetes is leading to an increased demand for insulin pumps.

Government Initiatives

Government actions are instrumental in shaping the India insulin pumps market. The Indian government has introduced a range of policies, programs, and subsidies to enhance access to insulin pumps and diabetes management technologies, especially for economically challenged individuals. This essay delves into the diverse facets in India, encompassing aspects, like accessibility, affordability, and the advancement of diabetes care technology, driven by the recognition of the growing diabetes burden.

As an example, in May 2023, the state government declared its intention to furnish complimentary insulin pumps to individuals with Type-1 diabetes. Given the substantial expense associated with insulin pumps, those hailing from economically challenged backgrounds find them financially inaccessible. Consequently, in the absence of these pumps, these patients resort to daily insulin injections, which elevates their susceptibility to severe infections affecting vital organs, such as the kidneys.

Rising Demand for Integrated Insulin Pumps

The India insulin pumps market is undergoing a significant evolution due to the introduction of integrated insulin pumps. This revolutionary technology merges insulin administration with continuous glucose monitoring (CGM), promising to revolutionize diabetes management. Integrated systems have the potential to redefine the way diabetes is controlled by offering real-time glucose data and automated insulin delivery, creating a seamless and highly precise method for managing blood sugar levels. The integrated insulin pumps are experiencing heightened demand owing to their capacity to improve blood sugar regulation and lower the risk of hypoglycaemia. As competition intensifies within the market, it is anticipated that the prices of integrated insulin pumps will decrease. The cost reduction will enhance affordability, making these devices more accessible to individuals managing diabetes.

Increasing Need for Insulin Pumps in Type 1 Diabetes

The rising need for solutions in Type 1 Diabetes has substantially led to the growth of India insulin pumps market. The demand for insulin pumps to manage Type 1 diabetes has witnessed a remarkable upswing, reflecting a pivotal shift in the realm of diabetes care. As Type 1 diabetes, an autoimmune condition characterized by insufficient insulin production, continues to affect millions worldwide, the need for advanced solutions to streamline insulin delivery and enhance glycaemic control has surged. For individuals, particularly youngsters, managing Type 1 diabetes, insulin pumps present a viable alternative. These devices can provide a consistent insulin supply, offering a reliable solution for those who may find it challenging to adhere to a strict schedule for insulin injections.

As an illustration, in March 2023, Medtronic unveiled the introduction of the MiniMed 780G system in the Indian market. This system, designed for individuals aged 7 to 80 years with type 1 diabetes, operates as a closed-loop insulin pump system. It harnesses Medtronic's SmartGuard technology to automate the administration of both basal insulin and correction boluses at five-minute intervals. This innovative approach assists individuals with diabetes in navigating their blood sugar levels with increased convenience, minimizing the occurrence of high and low glucose levels.

Impact of COVID-19

The COVID-19 pandemic had a twofold effect on the India insulin pumps market. It has negatively impacted the market due to disruptions in supply chains, limited access to healthcare facilities, and led to economic uncertainties. Import restrictions have resulted in shortages of insulin pumps and diabetes care products, hampering patient access to these devices. Additionally, reduced access to healthcare facilities has posed challenges for diabetes patients in receiving necessary care, including insulin pump therapy. Certain insurance providers have scaled back or entirely removed their coverage for insulin pumps, rendering them less accessible for individuals managing diabetes. However, the pandemic has increased awareness of managing chronic conditions like diabetes, potentially driving demand for insulin pumps. To ensure patient access to essential care and devices, market stakeholders must adapt to the evolving pandemic conditions.

Key Players Landscape and Outlook

The insulin pumps market in India is currently undergoing a significant shift with the rise of new entrants who are redefining the competitive terrain. Historically dominated by well-established healthcare companies, this market is now embracing innovative newcomers who bring fresh insights and state-of-the-art solutions. These emerging players are infusing dynamism into the industry by introducing novel technologies, promoting robust competition, and, most crucially, broadening the reach and affordability of insulin pumps to a wider cross-section of the Indian population.

In the realm of insulin pumps, Indian startups are leading the charge in innovation, reshaping the diabetes management landscape. Amid the growing prevalence of diabetes, these entrepreneurial ventures are leveraging their creativity to craft inventive solutions tailored to the specific requirements of diabetes management in India. For instance, in May 2023, Open MedLabs, an Indian startup, revealed its work on "InsuFlo," an open-loop insulin pump designed to be cost-effective for type-1 diabetic patients in resource-limited settings. The device has reached the prototype phase, demonstrating clinically precise insulin delivery. An upcoming animal study is planned. Ongoing efforts aim to elevate the device's Technology Readiness Level (TRL) and minimize its size to match competitors.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of Covid-19 on India Insulin Pumps Market

4. Executive Summary

5. India Insulin Pumps Market Outlook, FY2017-FY2031

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Type
  • 5.2.1. Standalone Insulin Pumps
  • 5.2.2. Sensor Integrated Insulin Pumps
• 5.3. By Product
  • 5.3.1. Pumps
    • 5.3.1.1. Tethered Pumps
    • 5.3.1.2. Patch Pumps
    • 5.3.1.3. Others
  • 5.3.2. Consumables
• 5.4. By Accessories
  • 5.4.1. Insulin Reservoir or Cartridges
  • 5.4.2. Insulin Set Insertion Devices
  • 5.4.3. Battery
• 5.5. By Disease Indication
  • 5.5.1. Type 1 Diabetes
  • 5.5.2. Type 2 Diabetes
• 5.6. By Age Group
  • 5.6.1 Adult
  • 5.6.2. Paediatrics
  • 5.6.3. Both
• 5.7. By End-user
  • 5.7.1. Hospitals
  • 5.7.2. Clinics
  • 5.7.3. Homeware
  • 5.7.4. Laboratories
• 5.8. By Distribution Channel
  • 5.6.1 Retail Stores
  • 5.6.2 Hospital Pharmacy
  • 5.6.3 E-commerce
• 5.9. By Region
  • 5.9.1. North
  • 5.9.2. South
  • 5.9.3. East
  • 5.9.4. West and Central
• 5.10. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

• 6.1. By Type
• 6.2. By Product
• 6.3. By Accessories
• 6.4. By Disease Indication
• 6.5. By Age Group
• 6.6. By End-user
• 6.7. By Distribution Channel
• 6.8. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 10.1 Clinical Trials
• 10.2 Patent Landscape
• 10.3 Regulatory Approvals
• 10.4 Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. India Medtronic Pvt. Ltd.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Agva Healthcare Pvt. Ltd.
• 13.3. Ypsomed India Pvt. Ltd.
• 13.4. Tandem Diabetes Care, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Insulin Pumps Market, By Value, In USD Billion, FY2017-FY2031F
• Figure 2. India Insulin Pumps Market, By Volume, In Units, FY2017-FY2031F
• Figure 3. India Insulin Pumps Market Share (%), By Type, FY2017-FY2031F
• Figure 4. India Insulin Pumps Market Share (%), By Product, FY2017-FY2031F
• Figure 5. India Insulin Pumps Market Share (%), By Accessories, FY2017-FY2031F
• Figure 6. India Insulin Pumps Market Share (%), By Disease Indication, FY2017-FY2031F
• Figure 7. India Insulin Pumps Market Share (%), By Age Group, FY2017-FY2031F
• Figure 8. India Insulin Pumps Market Share (%), By End-user, FY2017-FY2031F
• Figure 9. India Insulin Pumps Market Share (%), By Distribution Channel, FY2017-FY2031F
• Figure 10. India Insulin Pumps Market Share (%), By Region, FY2017-FY2031F
• Figure 11. By Type Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 12. By Product Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 13. By Accessories Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 14. By Disease Indication Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 15. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 16. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 17. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 18. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2023